PMED — Peptonic Medical AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK22.72m
- SEK15.14m
- SEK37.12m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | — | — | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -24.5 | -31.3 | -73.7 | -36.9 | -42.6 |
Non-Cash Items | 2.85 | 3.29 | 26.8 | 4.65 | 6.28 |
Other Non-Cash Items | |||||
Changes in Working Capital | 2.51 | -17.8 | 6.51 | -8.01 | 1.69 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -19.1 | -45.9 | -40.3 | -40.2 | -34.6 |
Capital Expenditures | -0.712 | -2.82 | -4.28 | -0.987 | -1.14 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | 12.9 | 0.476 | 0 | -2.69 |
Sale of Business | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.712 | 10.1 | -3.8 | -0.987 | -3.83 |
Financing Cash Flow Items | -1.78 | -1.29 | -0.015 | -3.44 | -13.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 44.5 | 39.1 | 15 | 34.6 | 50 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 24.6 | 3.33 | -29.2 | -6.59 | 11.6 |